#ResearchUpdate – Dr. Reddy’s Labs indicated medium term aspiration to achieve double digit sales growth and 25% EBITDA margin. Read more: http://ow.ly/LHf750JFn1MDisclaimer: http://ow.ly/i8rv50JFn1N #ResearchUpdate